Observing stroke trends in Matão, Brazil
Matão Preventing Stroke (MaPS): Stroke Register in City of Matão, Brazil
This study looks at stroke patterns in Matão, Brazil, to see how often they happen and what factors are involved, helping to improve health strategies for the community.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 840 (estimated) |
| Sex | All |
| Sponsor | Centro Neurológico de Pesquisa e Reabiitação, Brazil Academic / other |
| Locations | 1 site (Matão, São Paulo) |
| Trial ID | NCT03391102 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the incidence and types of stroke in the city of Matão, Brazil, over a ten-year period. It will track first-ever strokes, case fatalities, risk factors, and post-stroke outcomes among the local population. By gathering high-quality epidemiological data, the study seeks to inform public health policies aimed at reducing the impact of stroke in the region. The research will involve monitoring stroke patients living in Matão, regardless of age, to provide a comprehensive understanding of stroke trends.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals living in Matão who experience their first-ever stroke.
Not a fit: Patients who do not reside in Matão or have a history of previous strokes will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved public health strategies and reduced stroke-related mortality and disability in Brazil.
How similar studies have performed: While community-based stroke studies have been conducted elsewhere, this specific approach in Matão is novel and aims to fill critical gaps in local epidemiological data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All suspected stroke patients living in Matão at an address belonging to the city were included, regardless of age. The stroke criteria were those defined by the Word Health Organization: "rapidly developing clinical symptoms and/or signs of focal and at time global loss of cerebral function, with symptoms lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin" 12 Although every stroke was recorded, only the first-ever-in-a-lifetime stroke was included in the analysis. Exclusion Criteria: Patients not living in Matão, who did not fulfill the clinical criteria for stroke, with CT or RMI scan findings incompatible with a clinical suspicion of stroke, and with clinical evidence of a previous stroke event.
Where this trial is running
Matão, São Paulo
- Hospital Carlos Fernando Malzoni — Matão, São Paulo, Brazil (Recruiting)
Study contacts
- Principal investigator: Cesar Minelli, PhD, — Hospital Carlos Fernando Malzoni
- Study coordinator: Cewsar Minelli, PhD, MD
- Email: cdminelli@yahoo.com.br
- Phone: +55-16-33823388
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.